(Total Views: 465)
Posted On: 03/12/2021 1:19:18 PM
Post# of 154899
Roche's Actemra
I just received an email for my corporate entity of dramatic increases in utilization at roughly $4000 per dose despite no EUA and to require usage criteria..
Desperate times indeed, wow how can we solve this?
I'm in the camp of submitting to FDA, demand a no instead of the slow roll,
what are we worried about SP decreasing on an actual letter?
I just received an email for my corporate entity of dramatic increases in utilization at roughly $4000 per dose despite no EUA and to require usage criteria..
Desperate times indeed, wow how can we solve this?
I'm in the camp of submitting to FDA, demand a no instead of the slow roll,
what are we worried about SP decreasing on an actual letter?
(2)
(0)
